MARKET

EKSO

EKSO

Ekso Bionics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.840
+0.030
+1.66%
Closed 16:00 05/27 EDT
OPEN
1.850
PREV CLOSE
1.810
HIGH
1.867
LOW
1.805
VOLUME
20.38K
TURNOVER
33.73K
52 WEEK HIGH
6.10
52 WEEK LOW
1.535
MARKET CAP
23.63M
P/E (TTM)
-2.0142
1D
5D
1M
3M
1Y
5Y
Ekso Bionics names Jerome Wong as interim CFO
Ekso Bionics Holdings (NASDAQ:EKSO) on Thursday announced the appointment of Jerome Wong as the company's interim chief financial officer, effective immediately. It comes after current CFO Jack Glenn resigned effective June
Seekingalpha · 2d ago
Ekso Bionics Appoints Jerome Wong Interim CFO
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Jerome Wong as Interim Chief Financial Officer following the departure of current C...
Benzinga · 2d ago
Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference
RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will present at the H.C. Wainwright Global Investmen...
GlobeNewswire · 05/17 20:05
90 Biggest Movers From Yesterday
  Losers
Benzinga · 05/10 09:11
40 Stocks Moving In Monday's Mid-Day Session
Gainers
Benzinga · 05/09 16:06
Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/28 21:35
Ekso Bionics Holdings Q1 EPS $(0.36) Beats $(0.41) Estimate, Sales $2.60M Miss $3.20M Estimate
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.41) by 12.2 percent. This is a 5.88 percent decrease over losses of $(0.34) per share
Benzinga · 04/28 20:13
Ekso Bionics Holdings GAAP EPS of -$0.36, revenue of $2.6M
Ekso Bionics Holdings press release (NASDAQ:EKSO): Q1 GAAP EPS of -$0.36. Revenue of $2.6M (+36.1% Y/Y).
Seekingalpha · 04/28 20:12
More
No Data
Learn about the latest financial forecast of EKSO. Analyze the recent business situations of Ekso Bionics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average EKSO stock price target is 11.00 with a high estimate of 11.00 and a low estimate of 11.00.
High11.00
Average11.00
Low11.00
Current 1.840
EPS
Actual
Estimate
-0.33-0.25-0.16-0.08
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 72
Institutional Holdings: 5.34M
% Owned: 41.61%
Shares Outstanding: 12.84M
TypeInstitutionsShares
Increased
7
153.38K
New
6
534.24K
Decreased
6
18.12K
Sold Out
3
76.36K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+3.80%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Chairman/Chief Executive Officer/Executive Director
Steven Sherman
President/Chief Operating Officer
Scott Davis
Chief Financial Officer/Secretary
John Glenn
Vice President
Jason Jones
Lead Director/Independent Director
Stanley Stern
Director
Corinna Lathan
Independent Director
Mary Cloyd
Independent Director
Charles Li
Independent Director
Rhonda Wallen
No Data
No Data
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products that augment human strength, endurance and mobility. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The Company operates through two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells and rents exoskeletons for applications in the medical markets. Its leading product in EksoHealth, the EksoNR, is a robotic exoskeleton used to provide physical therapy for patients with lower extremity impairment. EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Its products include EksoZeroG Arm and and EksoVest. EksoZeroG Arm is a mobile arm mount and EksoVest is an upper body exoskeleton.

Webull offers kinds of Ekso Bionics Holdings Inc stock information, including NASDAQ:EKSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EKSO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EKSO stock methods without spending real money on the virtual paper trading platform.